[Dynamic assessment of WT1 for predicting the relapse of acute myeloid leukemia patients with MLL rearrangements after hematopoietic stem cell transplantation]

Zhonghua Xue Ye Xue Za Zhi. 2022 Sep 14;43(9):785-787. doi: 10.3760/cma.j.issn.0253-2727.2022.09.013.

[Article in Chinese]

Authors

X X Liu¹, J Kong¹, S A Pan¹, J Liu¹, Y Z Qin¹, Y J Chang¹, Y Wang¹, X H Zhang¹, L P Xu¹, X J Huang¹, X S Zhao¹

Affiliation

¹ Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.

PMID: 36709175
PMCID: PMC9613485
DOI: 10.3760/cma.j.issn.0253-2727.2022.09.013

No abstract available

MeSH terms

Chronic Disease
Hematopoietic Stem Cell Transplantation*
Humans
Leukemia, Myeloid, Acute* / genetics
Leukemia, Myeloid, Acute* / therapy
Myeloid-Lymphoid Leukemia Protein / genetics
Neoplasm, Residual
Recurrence
WT1 Proteins / genetics

Substances

WT1 Proteins
Myeloid-Lymphoid Leukemia Protein
WT1 protein, human

Grants and funding

基金项目：国家自然科学基金（81870137）；国家自然科学基金创新群体项目（81621001）